| Item Type | Name |
|
Concept
|
Cardiovascular Diseases
|
|
Academic Article
|
Comparison of the HEART and TIMI Risk Scores for Suspected Acute Coronary Syndrome in the Emergency Department.
|
|
Academic Article
|
Dual-energy X-ray absorptiometry for quantification of visceral fat.
|
|
Academic Article
|
The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
|
|
Academic Article
|
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.
|
|
Academic Article
|
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
|
|
Academic Article
|
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.
|
|
Academic Article
|
The Intersection of Diabetes and Cardiovascular Disease-A Focus on New Therapies.
|
|
Academic Article
|
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
|
|
Academic Article
|
Setting the Agenda for Preventive Cardiology.
|
|
Academic Article
|
Application of PCSK9 Inhibitors in Practice.
|
|
Academic Article
|
Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
|
|
Academic Article
|
The PCSK9 revolution: Current status, controversies, and future directions.
|
|
Academic Article
|
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
|
|
Academic Article
|
Aspirin for Primary Prevention of Cardiovascular Disease.
|
|
Academic Article
|
Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.
|
|
Academic Article
|
PCSK9: From Basic Science Discoveries to Clinical Trials.
|
|
Academic Article
|
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
|
|
Academic Article
|
PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
|
|
Academic Article
|
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology.
|
|
Academic Article
|
A multifaceted approach for management of prediabetes and its associated cardiovascular risk.
|
|
Academic Article
|
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science.
|
|
Academic Article
|
Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.
|
|
Academic Article
|
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).
|
|
Academic Article
|
Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA.
|
|
Academic Article
|
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
|
|
Academic Article
|
Association Between Alcohol Consumption and Ectopic Fat in the Multi-Ethnic Study of Atherosclerosis.
|
|
Academic Article
|
Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States.
|
|
Academic Article
|
Availability of Specialty Services for Cardiovascular Prevention Practice in the Southeastern United States.
|
|
Academic Article
|
Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis.
|
|
Academic Article
|
The Role of Sleep in Cardiovascular Disease.
|
|
Academic Article
|
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome.
|
|
Academic Article
|
Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia.
|
|
Academic Article
|
Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease.
|
|
Academic Article
|
Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study.
|
|
Academic Article
|
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
|
|
Academic Article
|
Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults.
|
|
Academic Article
|
Temporal Trends in Substance Use and Cardiovascular Disease-Related Mortality in the United States.
|
|
Academic Article
|
The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes.
|
|
Academic Article
|
Coronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South Florida.
|
|
Academic Article
|
Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study.
|
|
Academic Article
|
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database.
|
|
Academic Article
|
Lipoprotein(a) in clinical practice: A guide for the clinician.
|
|
Academic Article
|
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.
|
|
Academic Article
|
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?
|
|
Academic Article
|
Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events.
|
|
Academic Article
|
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.
|
|
Academic Article
|
Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention.
|
|
Academic Article
|
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
|
|
Academic Article
|
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.
|
|
Academic Article
|
Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
|
|
Academic Article
|
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
|
|
Academic Article
|
Should a Statin be Given to All Hypertensive Patients?
|
|
Academic Article
|
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know.
|
|
Academic Article
|
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.
|
|
Academic Article
|
Physical Activity, Coronary Artery Calcium, and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA).
|
|
Academic Article
|
The Questions on Everyone's Mind: What is and Why Do We Need Preventive Cardiology?
|
|
Academic Article
|
Ten things to know about ten cardiovascular disease risk factors.
|
|
Academic Article
|
Inflammation and Cardiovascular Disease: The Future.
|
|
Academic Article
|
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
|
|
Academic Article
|
Bridging the Gap Between Cardiology and Family Medicine.
|
|
Academic Article
|
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
|
|
Academic Article
|
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
|